VioQuest Pharmaceuticals Submits 510(k) Application To FDA For Xyfid™, A Novel Topical Agent For The Treatment Of Various Skin Disorders
VioQuest Pharmaceuticals (OTCBB: VOQP) announced the submission of a 510(k) application to the United States Food and Drug Administration (FDA).
This post is an original post by ScienceDaily: Skin Care News
Posted: July 3rd, 2008 under skin health.
Comments: none
